While standard IVF medications are essential for egg development, ovulation, and implantation, many patients explore adjunctive treatments to improve outcomes — especially after failed cycles or if diagnosed with diminished ovarian reserve, endometriosis, or unexplained infertility. Though some of these therapies are evidence-supported, others remain controversial.

🔹 1. Growth Hormone (GH)

Use: Often prescribed for patients with poor ovarian response or advanced maternal age.

How it works:
Growth hormone may improve the quality of oocytes by influencing IGF-1 (insulin-like growth factor), which supports follicular development and granulosa cell function.

Protocol:
Typically administered during stimulation, often from cycle day 2–6 onward.

Evidence:
Mixed. Some small trials show improved embryo quality and pregnancy rates in poor responders; others show no benefit. Best used in individualized protocols.

🔹 2. DHEA (Dehydroepiandrosterone)

Use: For women with diminished ovarian reserve or high FSH.

How it works:
A weak androgen precursor, DHEA may improve the follicular environment, increase antral follicle count, and enhance response to gonadotropins.

Dosage:
Usually 25 mg three times daily for 6–12 weeks before IVF.

Evidence:
Supported by some meta-analyses for improving AMH, follicle count, and possibly live birth rate in low responders.

🔹 3. CoQ10 (Coenzyme Q10)

Use: To support mitochondrial function and improve egg quality, especially in women over 35.

Mechanism:
Antioxidant that enhances ATP production in oocytes.

Dosage:
Typically 200–600 mg/day for at least 6–8 weeks prior to retrieval.

Evidence:
Emerging studies suggest improved fertilization rates and embryo quality.

🔹 4. Immune Modulators (Prednisone, Intralipids, Lovenox®)

Use: Recurrent implantation failure or suspected immune dysfunction.

• Prednisone: Corticosteroid to reduce inflammation

• Intralipids: IV fat emulsion that modulates NK cell activity

• Lovenox® (Enoxaparin): Low molecular weight heparin to improve uterine blood flow and address clotting disorders

Evidence:
Controversial. Often used in immunological protocols (e.g., for antiphospholipid syndrome), but large studies are lacking. Considered after recurrent loss or failed transfers.

🔹 5. Antibiotics (e.g., Doxycycline)

Use: Pre-transfer, to reduce risk of subclinical uterine infection or endometritis.

Protocol:
Common in frozen embryo transfer (FET) cycles or following hysteroscopy findings.

🔹 6. Supplements and Nutraceuticals

Supplement Purpose Vitamin D Supports endometrial receptivity and immune balance Myo-Inositol Improves egg quality, especially in PCOS patientsOmega-3sAnti-inflammatory, supports implantation Melatonin Antioxidant, may improve sleep and egg quality NAC (N-acetylcysteine)Anti oxidant, used in PCOS or inflammation

Note: Always consult a fertility specialist before adding supplements, as interactions with IVF medications can occur.

⚖️ A Word on Personalization

Many of these adjuncts are chosen case-by-case. While some show promise, others are empirical — meaning they’re used based on clinical experience rather than large randomized trials. Patients should weigh cost, invasiveness, and potential benefit when considering add-ons.